Technology

📈 From Fingersticks to the Future: How CGM is Transforming Gestational Diabetes Care

At Atlanta Perinatal Associates, weve taken that message to heartand to code.

By Dr. Chukwuma Onyeije, MD, FACOG

Maternal-Fetal Medicine Specialist & Medical Director, Atlanta Perinatal Associates

Founder, Doctors Who Code · OpenMFM.org · CodeCraftMD ·

“The best time to innovate is before everyone else catches up.”

At Atlanta Perinatal Associates, we’ve taken that message to heart—and to code.

DEEPER DIVE PODCAST:

🔍 Why This Matters Now

The era of fingerstick glucose monitoring in pregnancy may soon be a relic of the past. Thanks to a game-changing policy update, Medicaid now covers continuous glucose monitoring (CGM) for all pregnant patients with gestational diabetes mellitus (GDM) as of July 2025.

That single shift opens the door to smarter, real-time glycemic control—and we’re stepping through.

Our team, led by Jill Antisell, CNM, has launched a robust clinical protocol for CGM implementation. It’s more than a workflow upgrade; it’s a philosophical shift in how we care for patients. And if you’re a digital health innovator, clinician-coder, or MFM provider, this is your signal to lean in.

⚙️ The Tech and Workflow Behind the Transformation

The move from standard glucometers to CGMs like Dexcom G7 and Freestyle Libre 3 offers a continuous stream of glucose data via sensors worn on the skin. These devices sync with smartphones or receivers, offering trend arrows, customizable alerts, and real-time insight into the patient’s glucose landscape—all without a single fingerstick.

Our Protocol Highlights:

  • Eligibility: Any GDM patient—especially those on insulin or with glucose variability.

  • Device Selection: Dexcom G7 (10-day wear) or Freestyle Libre 3 (14-day wear), with Dexcom preferred for mobile integration.

  • Prescriptions:

  • Traditional Medicaid: via Aeroflow

  • Managed Medicaid Plans: sent to plan-specific pharmacies

  • Billing Codes:

  • 95249: Sensor placement (patient brings device)

  • 95250: Sensor placement (clinic provides device)

  • 95251: Interpretation of CGM data (≥72 hrs)

📊 Clinical Goals:

  • Target Time in Range (TIR): ≥ 80%

  • Glucose target range during pregnancy: 63–140 mg/dL

  • Postprandial targets:

  • Fasting: < 95 mg/dL

  • 1-hour: < 140 mg/dL

  • 2-hour: < 120 mg/dL

💡 Why It’s More Than Just Monitoring

Here’s where the clinician-coder mindset comes in.

We aren’t just adopting new tools—we’re redefining what quality care looks like using tech-informed decision support. CGM data isn’t just for patient feedback; it’s for clinical decision optimization, trend tracking, and proactive treatment adjustment.

Example Integrations:

  • Sync data to Dexcom Clarity or LibreView for team review

  • Set personalized alerts in-app

  • Use logged events (meals, activity, stress) to interpret trends

  • Monthly review cadence supports reimbursement via 95251

This integration of sensor tech + protocol + EMR automation is what makes CGM a blueprint for digital maternal-fetal medicine. And we’re not just using the tools—we’re coding the future.

🛠️ For Fellow Clinician-Developers: Code This into Your Practice

Whether you’re building a remote monitoring dashboard, optimizing an EHR integration, or launching a CGM-focused app, here are three actionable takeaways:

  1. Standardize Input: Use CPT coding logic (9524995251) to automate documentation templates.

  2. Track TIR Metrics: Pull 63–140 mg/dL TIR into clinician dashboards for smart alerts or color-coded decision aids.

  3. Empower Patients: Use Dexcom or Libre APIs for real-time data sharing, event annotation, and feedback loops.

🧠 The Takeaway

By adopting CGM now, we’re not just improving patient care—we’re shaping the standard of care. The sooner we fuse clinical innovation with data literacy, the more equipped we’ll be to tackle the next wave of personalized prenatal medicine.

To the innovators, midwives, coders, and clinicians leading this transition—we got this.

📎 Resources

📬 Questions? Contact Dr. Onyeije at Atlanta Perinatal Associates

Published: July 2025 | Doctors Who Code

Share X / Twitter LinkedIn
Chukwuma Onyeije, MD, FACOG

Chukwuma Onyeije, MD, FACOG

Maternal-Fetal Medicine Specialist

MFM specialist at Atlanta Perinatal Associates. Founder of CodeCraftMD and OpenMFM.org. I write about building physician-owned AI tools, clinical software, and the case for doctors who code.